Frances Oldham Kelsey papers, 1890-2016 (Library of Congress Finding Aid)

Access restrictions apply.Some or all content stored offsite.

Container	Contents

	Part II: Subject File, 1902-2012 (continued)
		Congenital malformations review papers, 1957-1985, undated (continued)
			(5 folders)
BOX II:120		Congressional
BOX II:120			Hearings
BOX II:120				House of Representatives
BOX II:120					Commission on the Federal Drug Approval Process (McMahon Commission)
BOX II:120						1981-1988
BOX II:120							(4 folders)
BOX II:121						1996-1999, undated
BOX II:121							(2 folders)
BOX II:121					Drug Safety, 1964
BOX II:121						(2 folders)
BOX II:121					Fraud in biomedical research, 1981
BOX II:121					National Ambient Air Quality Standards, 1984
BOX II:121					Use of Advisory Committees by the U.S. Food and Drug Administration (Fountain Committee), 1982, 1997-1999
BOX II:121				Senate
BOX II:121					Interagency Coordination in Drug Research Regulation
BOX II:121						1961 See Oversize
BOX II:121						1962
BOX II:121							Mar.-May
BOX II:121							Aug.
BOX II:121								(1 folder)
BOX II:122								(4 folders)
BOX II:122						1963
BOX II:122					Investigation of drug industry (Estes Kefauver), 1960-1964, 1997
BOX II:122					United States Government and the future of international medical research, 1961
BOX II:123			Miscellany
BOX II:123				Questions, undated
BOX II:123				Testimony, 1960-1961, 1970, 2000
BOX II:123					(4 folders)
BOX II:123			Reports
BOX II:123				House of Representatives, circa 1963-1966
BOX II:123					(2 folders)
BOX II:123				Office of Technology Assessment, 1974-1976
BOX II:124				Senate, 1960-1966
BOX II:124					(2 folders)
BOX II:124		Consumer information publications by U.S. Food and Drug Administration, 1956-1988, undated
BOX II:124			(4 folders)
BOX II:124		Contracts and Grants Review Committee, 1988-1989
BOX II:124			(2 folders)
BOX II:124		Contracts for studies
BOX II:124			Auerbach Associates, FDA 72-63, 1972
BOX II:125			Center for Disease Control, possible contract, 1973
BOX II:125			Children’s Hospital Research Foundation, Cincinnati, Ohio
BOX II:125				FDA 68-44, FDA 70-7, FDA 71-11
BOX II:125					1967-1970
BOX II:125						(7 folders)
BOX II:126					1971-1976
BOX II:126						(5 folders)
BOX II:126				FDA 641-8-131, 1968
BOX II:126			Mayo Foundation, Rochester, Minn., FDA 72-339, FDA 7837-73(B)
BOX II:126				1971-1973
BOX II:126					(2 folders)
BOX II:127				1974-1976
BOX II:127			National Academy of Sciences-National Research Council, FDA 70-22, FDA 71-52, FDA 72-1, 1970-1974, 1999
BOX II:127				(2 folders)
BOX II:127			University of Miami, Miami, Fla.
BOX II:127				FDA 66-210, 1967-1968
BOX II:127				FDA 67-54, FDA 68-47, FDA 69-34
BOX II:127					1967-1970
BOX II:127						(4 folders)
BOX II:128					1971-1975, 1999
BOX II:128				FDA 641-8-157, 1968-1973
BOX II:128		Control and dispensing of drugs, 1960-1963, 1996, undated
BOX II:128		Coulston Foundation, Alamogordo, N. Mex./Frederick Coulston, 1966, 1992, 1998-2000
BOX II:128		Daroil, 1964-1965
BOX II:128		Darvon, 1979-1980 See also Container II:139, Eli Lilly and Co. Task Group
BOX II:128		Data handling of scientific information, 1959-1964, 1995-1999, undated
BOX II:128		Day, J. Edward, 1965, 1996, undated
BOX II:128		Day, Paul L., 1961, 1999, undated
BOX II:128		Definition of terms “drug” and “new drug,” undated
BOX II:128		Defoliants and herbicides See Container II:186, Pesticides and environmental hazards
BOX II:128		DeMarco, Peter See Container II:189, Procaine with polyvinylpyrrolidone (PVP)
BOX II:128		Depo-Provera, 1966, 1975-1984, undated
BOX II:128		DES (Drug), 1953, 1972-2000, undated
BOX II:128		DFMO (Drug), 2000-2001
BOX II:128		DHSM (Drug) See same container, Dihydrostreptomycin
BOX II:128		Dicumarol and related anticoagulants, 1970-1986, 1996-1997
BOX II:128		“Diet” pills, 1985, 1997-2001, undated
BOX II:128		Dietary supplements, 1982, 1998-2001, undated
BOX II:128		Diethyl glycol See Container II:139, Elixir sulfanilamide
BOX II:128		Diethylstilbestrol See same container, DES (Drug)
BOX II:128		Difluoromethyl-ornithine See same container, DFMO (Drug)
BOX II:128		Dihydrostreptomycin (DHSM), 1959, undated
BOX II:128		Dimethyl sulfoxide See Containers II:135-II:136, DMSO (Drug)
BOX II:128		Diphenylhydantoin
BOX II:128			1963-1969
BOX II:129			1970-1998, undated
BOX II:129				(3 folders)
BOX II:129		Dithiocarb, 1963-1966, 1996, undated
BOX II:129		Diuretics, 1962-1966, 1972-1978, 1994, undated
BOX II:129		Division of Scientific Investigations, U.S. Food and Drug Administration
BOX II:129			Awards, division members, 1972-1983, undated
BOX II:129				(3 folders)
BOX II:129			Central file, 1989-1990, 1997, undated
BOX II:129				(1 folder)
BOX II:130				(1 folder)
BOX II:130			Clinical Investigations Branch
BOX II:130				Debarment of investigators, circa 1996
BOX II:130				Disqualified/restricted/assurance lists, 1970, 1980-1982, 1990-2000
BOX II:130					(3 folders)
BOX II:130				General
BOX II:130					1963-1981
BOX II:130						(3 folders)
BOX II:131					1982-1997, undated
BOX II:131						(5 folders)
BOX II:131				Warning letters to investigators, circa 1993-1998
BOX II:131			Institutional Review Branch
BOX II:131				1972-1979
BOX II:131				1980
BOX II:131					(1 folder)
BOX II:132					(2 folders)
BOX II:132				1981
BOX II:132					(3 folders)
BOX II:132				1982
BOX II:132					(1 folder)
BOX II:133					(3 folders)
BOX II:133				1983-1984, 1991, 1999, undated
BOX II:133					(3 folders)
BOX II:133			Nonclinical Laboratory Studies Branch
BOX II:133				Good laboratory practices See Containers II:147-II:148, same heading
BOX II:133				Significant investigations prior to June 20, 1979 (Government Accounting Office request), 1987
BOX II:133			Methadone Monitoring Branch See Container II:172, Methadone monitoring
BOX II:133			Paperwork systems and procedures, 1976-1978, 1999
BOX II:134			Policies and procedures, 1973-1990, undated
BOX II:134				(2 folders)
Next Page »

Frances Oldham Kelsey papers, 1890-2016

Contents List